MedPath

广东彼迪药业有限公司

Ownership
-
Established
1994-08-15
Employees
-
Market Cap
-
Website
http://www.pdpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

161

NMPA:161

Drug Approvals

Famciclovir Capsules

Product Name
彼欣
Approval Number
国药准字H20020184
Approval Date
May 14, 2024
NMPA

Alendronate Sodium Tablets

Product Name
阿仑膦酸钠片
Approval Number
国药准字H20093921
Approval Date
Mar 4, 2024
NMPA

Cefteram Pivoxil Tablets

Product Name
头孢特仑新戊酯片
Approval Number
国药准字H20133323
Approval Date
May 23, 2023
NMPA

Thiamphenicol Enteric-coated Tablets

Product Name
甲砜霉素肠溶片
Approval Number
国药准字H20073858
Approval Date
Mar 9, 2022
NMPA

Citicoline Sodium and Sodium Chloride Injection

Product Name
彼迪明
Approval Number
国药准字H20020319
Approval Date
Mar 9, 2022
NMPA

Ofloxacin and Sodium Chloride Injection

Product Name
氧氟沙星氯化钠注射液
Approval Number
国药准字H10940239
Approval Date
Jan 25, 2022
NMPA

Compound Amino Acid Injection(17AA)

Product Name
复方氨基酸注射液(17AA)
Approval Number
国药准字H19993672
Approval Date
Oct 28, 2021
NMPA

Compound Amino Acid Injection(15AA)

Product Name
复方氨基酸注射液(15AA)
Approval Number
国药准字H19999252
Approval Date
Oct 28, 2021
NMPA

Compound Amino Acid Injection(17AA-I)

Product Name
复方氨基酸注射液(17AA-Ⅰ)
Approval Number
国药准字H44024831
Approval Date
Oct 28, 2021
NMPA

Compound Amino Acid Injection(17AA-I)

Product Name
复方氨基酸注射液(17AA-Ⅰ)
Approval Number
国药准字H44025415
Approval Date
Oct 28, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.